SES AI (SES) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Oct, 2026Executive summary
Virtual annual meeting set for Dec. 10, 2026; voting record date Oct. 13, 2026. Five proposals cover director elections, auditor ratification, say-on-pay, reverse-split authority and officer exculpation.
Board seeks reverse-split flexibility to support NYSE listing compliance and officer exculpation to aid executive recruitment and retention.
Voting matters and shareholder proposals
Proposals: elect Eric Luo and Dr. Jiong Ma for terms ending in 2029; ratify Grant Thornton LLP for FY2026; approve FY2025 executive pay; authorize a 5:1–20:1 reverse split; approve officer exculpation.
Board recommends FOR all five proposals; director election requires a plurality, auditor and say-on-pay approval a majority of votes cast, and Proposals 4 and 5 two-thirds of outstanding voting power.
NYSE’s $1 minimum-price requirement must be cured by Jan. 17, 2027; if approved, the Board may set the split ratio and timing or abandon the amendment before filing.
Stockholders may submit director nominations or proposals for the 2027 meeting; advance-notice nominations are due Aug. 12–Sept. 11, 2027, subject to meeting-date changes and bylaw requirements.
Board of directors and corporate governance
Five directors serve on a classified Board; Eric Luo and Dr. Jiong Ma are nominated for new three-year terms. Dr. Hu combines CEO and Chair roles; Dr. Ma is independent Lead Director.
Controlled-company status applies because the CEO and affiliates hold over 50% of voting power; the Board nevertheless has a majority of independent directors, and the Compensation Committee is fully independent.
Four standing committees oversee audit, compensation, nominations and governance, and strategic investments and partnerships; independent directors meet in executive sessions without management.
The Board conducts annual evaluations of itself and its committees, covering composition, meetings, management relations, succession planning, strategy and performance.
Latest events from SES AI
- Q3 losses narrowed as drone capacity reached 1 million cells and FY26 guidance held.SES
Q3 2026 - Five proposals put NYSE listing, officer liability and executive pay before stockholders.SES
Proxy filing - Board backs all five proposals, including a 5:1 to 20:1 reverse split.SES
Proxy filing - B-Sample development advances toward 2027 commercialization amid losses and rising investment.SES
Q4 2023 - Q2 2026 revenue rose 44% to $5.1M, margin improved, but net loss and legal risks remain.SES
Q2 2026 - Shelf registration allows up to $300M in offerings, including $150M ATM equity sales.SES
Registration filing - Q1 2026 revenue up 47% sequentially to $6.7M, led by ESS, with guidance reaffirmed.SES
Q1 2026 - Q3 revenue rose 102% to $7.1M, with strong AI, ESS, and SaaS growth, but risks persist.SES
Q3 2025 - Record Q1 revenue of $5.8M, high margins, $30M buyback, and new platform launch ahead.SES
Q1 2025